The partners at Cancer Center of Kansas have heard for years about all the radical changes they must make to survive as a business. They have implemented those changes required by law, but they have stood firm against fads.
Andrew L. Pecora, MD, discusses his hopes for healthcare reform if the the Affordable Care Act is repealed.
Oncologists discuss their experience and best practices with phone triage programs.
Healthcare spending is one of the largest expenses for a company and, more and more, employers are using population-based Big Data to ensure their employees have coverage tailored to their needs at a reasonable cost.
Immuno-oncology drugs can improve the level of care in many respects, but they bring a host of problems related to implementation that demands a new set of strategies.
The primary goal of a cancer diagnosis is to end up with the best possible outcome, and there are always several highways of care, or bundles, to choose from.
The Republican push to repeal the Affordable Care Act has sent anxiety levels soaring among oncologists and their patients, due largely to the great uncertainty about how exactly Congress will proceed.
The FDA has granted a priority review to a supplemental Biologics License Application for pembrolizumab for the treatment of patients with locally advanced or metastatic urothelial cancer who progress following platinum-containing chemotherapy, according to Merck, the manufacturer of the PD-1 inhibitor.